Related Experiment Video
Updated: Aug 12, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
A retrospective study on genito urinary Rhabdomyosarcoma
M M Rahman1, T H Siddiqui, M R Amin
1Department of Paediatric Surgery, BSMMU, Dhaka, Bangladesh.
Mymensingh Medical Journal : MMJ
|August 2, 2003
Summary
Genitourinary rhabdomyosarcoma treatment in children showed promising results with chemoradiation therapy. Most pediatric patients achieved an asymptomatic status post-treatment, though some faced challenges with treatment completion and disease progression.
Area of Science:
- Pediatric Surgery
- Oncology
- Genitourinary Diseases
Background:
- Genitourinary rhabdomyosarcoma (GU-RMS) is a rare and aggressive pediatric malignancy.
- Effective management strategies are crucial for improving outcomes in affected children.
- This study examines treatment outcomes for GU-RMS in a Bangladeshi pediatric surgery department.
Purpose of the Study:
- To evaluate the efficacy of chemoradiation therapy and surgical intervention for genitourinary rhabdomyosarcoma in pediatric patients.
- To analyze treatment outcomes, including survival and complication rates.
- To provide insights into managing this rare cancer in a resource-limited setting.
Main Methods:
- A retrospective analysis of 13 pediatric patients diagnosed with genitourinary rhabdomyosarcoma between 1990 and 1999.
- Diagnosis confirmed through clinical examination, imaging (ultrasonography, IVU, CT scan), and biopsy.
- Treatment involved neoadjuvant chemoradiation followed by surgical excision for residual tumors.
Main Results:
- Eight out of thirteen patients (61.5%) were asymptomatic after completing chemoradiation.
- Three patients (23.07%) discontinued the treatment schedule.
- One patient with residual mass underwent partial cystectomy and died postoperatively; another with pulmonary metastasis died during treatment.
Conclusions:
- Chemoradiation therapy as a primary treatment modality shows potential for managing pediatric genitourinary rhabdomyosarcoma.
- Treatment adherence and management of metastatic disease remain critical challenges.
- Further research is needed to optimize treatment protocols and improve survival rates for pediatric GU-RMS.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...